Press Releases
Utica Native Kevin Byrd advocacy work honored and entered into Congressional Record | PRLog
Utica Native Kevin Byrd advocacy work honored and entered into Congressional Record. Utica Native Kevin Byrd Youngest Prostate Cancer Advocate in U.S. and New Health & Wellness Chairman for the 100 work is honored by Congressional Record Honoring February 2, 2012 Prostate Cancer Awareness
Sinaiko Urology Announces Launch of HIFU Prostate Treatment Blog
Renown urologist, Peter Sinaiko, MD FACS, launches new blog to educate patients, medical professionals and regulators about the efficacy of HIFU therapy for treatment of prostate cancer. The blog is located at http://www.hifuprostatecancerdoctor.com.
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
What everyone should know about prostate cancer with Professor Stephen Langley
< div class= " section " > < a name= " " class= " anchor " > < /a > < h3 class= " heading " > What everyone should know about prostate cancer with Professor Stephen Langley < /h3 > < div class= " body " > < div class= " copy " > < p > < strong > 12 < sup > th < /sup > July, 7pm, Education Centre <
Genetic Technology Alert. Effect of Progerin in Prostate Cancer Development; Aptamer-Based Rapid
This issue profiles the effect of progerin in prostate cancer development, an aptamer-based rapid proteomics discovery platform for biomarkers, and bioinformatics tools that aid in high-throughput genomic data analysis. Strategic partnership details and some important patents have also been
Marshfield Clinic - News Releases
Did you know that in 2010, more than 217,000 American men–and more than 4,000 in Wisconsin–will be told they have prostate cancer, according to the American Cancer Society? In fact, in 2010, 32,000 American men and 600 Wisconsin men will die from the disease.
Dr Foster Health Publishes New Waiting Times Update for Transurethral Resection of Prostate (TURP)
Dr Foster Health, the hospital comparison and consultant search website, has published a new Waiting Times Update for Transurethral Resection of Prostate (TURP) surgery alongside two new Information Hubs revealing the facts behind TURP Surgery and Prostate Cancer.
Myriad Genetics, Inc. - Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer
Myriad Genetics, Inc. Logo Print Print page Email Email page PDF Download PDF Add to Briefcase « Previous Release Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer Outcome Study to be Published in Lancet Oncology Journal SALT LAKE CITY , Feb. 9,
HOPKINS RESEARCHERS FIND A BETTER BLOOD TEST FOR PROSTATE CANCER
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer Without Toxicity | PRLog
Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer Without Toxicity. Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors. - PR11794092
Refine by Content Type:
Refine by Source:
- www.prlog.org (84)
- www.prweb.com (13)
- investor.myriad.com (8)
- www.hopkinsmedicine.org (7)
- www.frost.com (3)
- www.abbott.com (2)
- marshfieldclinic.org (1)
- www.prleap.com (1)
- www.royalsurrey.nhs.uk (1)
